Sysco Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial ReportiCD ResearchFebruary 6, 2012 38 Pages - SKU: ICDR6792369 |
| Synopsis ICD Research's Sysco Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's Sysco Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Sysco Corporation. ICD Research's Sysco Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Sysco Corporation (Sysco) is a food products marketing and distribution company. It sells markets and distributes food products to restaurants, healthcare and educational facilities, hotels and inns, and other food-service and hospitality businesses. Sysco markets its own quality Sysco brands and other major national, regional and ethnic brands, and local foods. The company operates from more than 180 locations throughout the US, Canada and Ireland, serving over 400,000 customers, with over 14,000 sales and marketing representatives and 177 distribution facilities throughout the US, Canada and Ireland. Sysco is headquartered in Houston, Texas, the US. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

